Status:
COMPLETED
Multidisciplinary Management of HCC in Elderly Patients
Lead Sponsor:
Azienda Policlinico Umberto I
Conditions:
HCC
Quality of Life
Eligibility:
All Genders
65+ years
Brief Summary
Aim of this study is to evaluate whether treating HCC recurrences in resected elderly patients is advantageous or not.
Detailed Description
Introduction- Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. It usually develops in cirrhotic liver with high recurrence rates. More than 2/3 of patients are elderly, ofte...
Eligibility Criteria
Inclusion
- HCC patient
- eligible for surgery
Exclusion
- non eligible for surgery at first HCC diagnosis
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03875417
Start Date
January 1 2018
End Date
October 31 2018
Last Update
March 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery "Pietro Valdoni"
Roma, Italy, 00161